Helixmith pens CRO contract with WTC to test Engensis in US ALS patients
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Shares of Kosdaq-listed Helixmith closed the day 4.6 percent higher at 50,000 won ($42.19) on the news.
WTC, a global CRO providing full-service drug development services infrastructure and talent spanning 60 countries, focuses on central nervous system, cardiovascular and metabolic disorders, general medicine, oncology and rare diseases with high unmet medical needs.
ALS is a fatal neurological disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control. ALS often called Lou Gehrig's disease causes progressive physical disabilities and leads to eventual death due to respiratory muscle failure.
The incidence of ALS is 1 per 20,000 each year and it affects about 30,000 people in the U.S. alone. Currently, there is no cure for ALS or effective treatment to stop the progression of the disease.
Engensis is a plasmid-based gene therapy to deliver the hepatocyte growth factor (HGF) directly to patient cells, capable of regenerating microvasculature and nerve cells and preventing muscular atrophy with excellent safety profile, according to the company.
The US FDA recognized the potential for Engensis to meet the unmet need for this condition in 2016 by granting it orphan drug designation plus a fast track regulatory review for marketing approval.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- Stricter social distancing restrictions land hard on small businesses in Korea - Pulse by Maeil Business News Korea
- Korean gov’t endorses 4th extra budget of $6.6bn, first since 1961 - Pulse by Maeil Business News Korea
- SK Group’s vaccine stocks jolted on AstraZeneca’s trial pause - Pulse by Maeil Business News Korea
- Hancom acquires local drone, aerospace solutions developer to broaden business - Pulse by Maeil Business News Korea
- NCSoft invites the first world siege of Lineage 2M on Sept. 13 - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 영업이익률 40% 넘는 저가 커피 [편집장 레터]
- 하니, ‘10살 연상’ ♥양재웅과 결혼 발표 “함께하고 싶은 사람 만나”...EXID 첫 유부녀 탄생 - M
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이